SMART-M24: A Prognostic Nomogram for Long-Term Mortality in Acute Ischemic Stroke Beyond 24 H from Symptom Onset
- PMID: 40488807
- DOI: 10.1007/s12975-025-01361-1
SMART-M24: A Prognostic Nomogram for Long-Term Mortality in Acute Ischemic Stroke Beyond 24 H from Symptom Onset
Abstract
Prognostication after acute ischemic stroke is crucial for long-term care plans. Although hyperacute management significantly affects outcomes, prognostic factors for patients receiving delayed care remain unknown. This study aimed to evaluate predictors and develop a method for estimating long-term mortality in patients with delayed hospital arrival 24 h after stroke symptom onset. Between January 2008 and December 2014, ischemic stroke patients who were admitted to the hospital more than 24 h from symptom onset were included in the linked dataset provided by the Clinical Research Center for Stroke, linked with claims data from the Health Insurance Review and Assessment Service. A nomogram was developed to estimate long-term mortality using clinical variables, with a predictive model assessed by Harrell's C-index. A total of 14,298 patients with acute ischemic stroke (66.5 years, mean age; 58.3%, male) were randomly assigned to training (n = 10,009) and validation (n = 4289) groups. Significant predictors of long-term mortality included older age, lower BMI, higher NIHSS score, stroke etiology, comorbidities (diabetes, coronary artery disease, dialysis, cancer), fasting blood sugar, use of antithrombotics/statins, and functional status at discharge. The Stroke Measures Analysis for Prognostic Testing - Mortality24 (SMART-M24) nomogram incorporated 17 predictors and achieved a C-index of 0.80 (95% CI, 0.79-0.81) in both groups. The SMART-M24 nomogram provides a prognostic tool for estimating long-term mortality in ischemic stroke patients with delayed hospital arrival 24 h after symptom onset. This model can assist clinical decision-making and long-term care planning for patients who have not undergone hyperacute treatment.
Keywords: Delayed diagnosis; Ischemic stroke; Long-term mortality; Nomogram; Prediction system; Treatment delay.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval and Consent to Participate: This study was conducted following the principles outlined in the Declaration of Helsinki. It was approved by the Institutional Review Board of Seoul National University Hospital (H-1608–078-785 and H-2306–044-1437). Informed consent was waived because this study was conducted retrospectively. Competing interests: The authors declare no competing interests.
References
-
- Cha YJ. The economic burden of stroke based on South Korea’s National Health Insurance Claims Database. Int J Health Policy Manag. 2018;7:904–9. https://doi.org/10.15171/ijhpm.2018.42 . - DOI - PubMed - PMC
-
- Wang G, Zhang Z, Ayala C, et al. Costs of hospitalization for stroke patients aged 18–64 years in the United States. J Stroke Cerebrovasc Dis. 2014;23:861–8. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.017.8 . - DOI - PubMed
-
- Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649–55. https://doi.org/10.1212/wnl.55.11.1649 . - DOI - PubMed
-
- Kim M, Lee JS, Lee SJ, et al. Effectiveness of intravenous thrombolysis in patients with large-vessel occlusion receiving endovascular treatment in Korea. Acute Crit Care. 2025. https://doi.org/10.4266/acc.004248 . Accessed 11 Apr 2025.
-
- Kim BJ, Menon BK, Kim JY, et al. Endovascular treatment after stroke due to large vessel occlusion for patients presenting very late from time last known well. JAMA Neurol. 2020;78:21–89. https://doi.org/10.1001/jamaneurol.2020.2804 . - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Medical